LONDON/BENGALURU April 3 (Reuters) - Drugmaker stocks gained a temporary reprieve ... the president plans separate tariffs targeting the pharma sector. Trump in his White House Rose Garden ...

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy. Also read: Front-end manufacturing in U.S ...

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are ...

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from imposing new tariffs on the sector. While electronics and gems are hit by ...

However, according to a fact sheet released by the White House, pharmaceuticals were exempted from these higher tariffs. The exemption from reciprocal tariffs, Tausif Shaikh, India analyst - pharma ...

Currently, US charges nearly zero duty on pharmaceutical imports, while India imposes around 10 percent tax on pharma imports from US. Domestic pharma companies are fearful of any potential impact ...

Indian pharmaceutical stocks soared after the US exempted drugs from reciprocal tariffs. Gland Pharma and Aurobindo Pharma led the rally, gaining over 14% and 9% respectively. New Delhi, Apr 3 (PTI) ...

Despite being exempted from tariffs, Indian pharmaceutical stocks have already reacted to the potential risk of future levies. The Indian pharma index has declined by nearly 10 per cent in the ...

Though the pharma stocks have come down significantly from 1-year highs, the investors are still looking for bargain buys. Moreover, the selling pressure has been further exacerbated by the lack ...

Pharma companies truly deserve to be called 'defensive stocks' for these reasons and more. Going by the same logic, pharma stocks should be resilient and consistent in delivering gains year after ...

Stock market today: Indian pharma stocks extended their losing streak to the third consecutive trading session on Thursday, March 27, as concerns grew that US President Donald Trump may announce ...